Co-expression of IL-4/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment-Reference-Cited by-同舟云学术

Co-expression of IL-4/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment

Published:2023-12 Issue: Volume:168 Page:115740
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhou Ying,Farooq Muhammad Asad,Ajmal Iqra,He Cong,Gao Yaoxin,Guo Dandan,Duan Yixin^ORCID,Jiang Wenzheng

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference35 articles.

1. CART cell therapy and the tumor microenvironment: current challenges and opportunities;Fonkoua;Mol. Ther. Oncolytics.,2022

2. Suppression of 4.1 R enhances the potency of NKG2D-CAR T cells against pancreatic carcinoma via activating ERK signaling pathway;Gao;Oncogenesis,2021

3. Co-expression of IL-7 improves NKG2D-based CAR T cell therapy on prostate cancer by enhancing the expansion and inhibiting the apoptosis and exhaustion;He;Cancers,2020

4. NKG2D signaling shifts the balance of CD8 T cells from single cytokine-to polycytokine-producing effector cells;Kohlhapp;Mol. Immunol.,2023

5. Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis;Jiang;Cancer Immunol. Immunother.,2023

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies;Biomedicine & Pharmacotherapy;2024-09

2. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy;Molecular Cancer;2024-08-26

3. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors;Cellular & Molecular Immunology;2024-08-12

4. shRNA-mediated gene silencing of HDAC11 empowers CAR-T cells against prostate cancer;Frontiers in Immunology;2024-05-21

5. Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence;Cells;2024-01-04